Preparation and optimization of chlorophene-loaded nanospheres as controlled release antimicrobial delivery systems

Pharmaceutical Development and Technology

Volumn 21, Issue 1, 2016, Pages 8-13

  Phuengkham, Hathaichanok ^a,b   Teeranachaideekul, Veerawat ^c   Chulasiri, Malyn ^c   Nasongkla, Norased ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SJI ^*  (Thailand)

^c SJI   (Thailand)

Author keywords

Antimicrobial; chlorophene; controlled release; nanospheres

Indexed keywords

ACETIC ACID ETHYL ESTER; CLOROFENE; NANOSPHERE; POLOXAMER; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; DICHLOROPHEN;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; HEMOLYSIS; HOSPITAL INFECTION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SUSTAINED DRUG RELEASE; ANALOGS AND DERIVATIVES; CHEMISTRY; DELAYED RELEASE FORMULATION; DOSE RESPONSE; DRUG EFFECTS; HUMAN; MEDICINAL CHEMISTRY; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; PROCEDURES; SYNTHESIS;

ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DICHLOROPHEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; HUMANS; MICROBIAL SENSITIVITY TESTS; NANOSPHERES; STAPHYLOCOCCUS AUREUS;

EID: 84955152658     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2014.959180     Document Type: Article

References (30)

1. Goldmann DA, Freeman J, Durbin WA. Nosocomial infection and death in a neonatal intensive care unit. J Infect Dis 1983; 147: 635-641
2. Klevens RM, Edwards JR, Richards CL, et al. Estimating health care-Associated infections and deaths in US hospitals, 2002. Public Health Rep 2007; 122: 160
3. Yokoe DS, Mermel LA, Anderson DJ, et al. A compendium of strategies to prevent healthcare-Associated infections in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29: S12-S21
4. Andersen FA. Safety assessment of dichlorophene and chlorophene. Int J Toxicol 2004; 23: 1-27
5. Stouten H, Bessems JGM. Toxicological profile for o-benzyl-p-chlorophenol. J Appl Toxicol 1998; 18: 271-279
6. Jeong Y-I, Na H-S, Seo D-H, et al. Ciprofloxacin-encapsulated poly (DL-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int J Pharm 2008; 352: 317-323
7. Park MJ, Balakrishnan P, Yang SG. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine. Int J Pharm 2013; 441: 757-764
8. Cauchetier E, Deniau M, Fessi H, et al. Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics. Int J Pharm 2003; 250: 273-281
9. Durán N, De Oliveira AF, De Azevedo MMM. In vitro studies on the release of isoniazid incorporated in poly(ε-caprolactone). J Chemotherapy 2006; 18: 473-479
10. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001; 70: 1-20
11. Lavasanifar A, Samuel J, Kwon GS. Micelles self-Assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-Aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. J Control Release 2001; 77: 155-160
12. Nasongkla N, Bey E, Ren J, et al. Multifunctional polymeric micelles as cancer-Targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006; 6: 2427-2430
13. Nasongkla N, Boongird A, Hongeng S, et al. Preparation and biocompatibility study of in situ forming polymer implants in rat brains. J Mater Sci-Mater Med 2012; 23: 497-505
14. Lee WK, Park JY, Yang EH, et al. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- And nanoparticles prepared by high-pressure homogenizer. J Control Release 2002; 84: 115-123
15. Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2009; 26: 1025-1058
16. Wang Y, Jiang G, Qiu T, Ding F. Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery. Drug Dev Ind Pharm 2012; 38: 1039-1046
17. Vandervoort J, Yoncheva K, Ludwig A. Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles. Chem Pharm Bull 2004; 52: 1273-1279
18. Dinda A, Biswal I, Das D, et al. Effect of stabilizers and process parameters for budesonide-loaded PLGA-nanoparticles. Int J Drug Deliv 2011; 1: 371-380
19. Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm 2007; 336: 367-375
20. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317
21. Mittal A, Kumar N. Drug-loaded polymeric composite skin graft for infection-free wound healing: fabrication, characterization, cell proliferation, migration, and antimicrobial activity. Pharm Res 2012; 29: 3110-3121
22. Jeong YI, Na HS, Seo DH, et al. Ciprofloxacin-encapsulated poly(dl-lactide-co-glycolide) nanoparticles and its antibacterial activity. Int J Pharm 2008; 352: 317-323
23. Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998; 24: 1113-1128
24. Rousseau G, Jeffs P. International conference on harmonization impurity guidelines-The industry perspective. Drug Inf J 2000; 34: 903-907
25. Sahana DK, Mittal G, Bhardwaj V, Kumar MNVR. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharm Sci 2008; 97: 1530-1542
26. Wei L, Marasini N, Li G, et al. Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution. Int J Pharm 2012; 437: 203-212
27. Yan F, Zhang C, Zheng Y, et al. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomed-Nanotechnol 2010; 6: e170-e178
28. Doan TVP, Couet W, Olivier JC. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Int J Pharm 2011; 414: 112-117
29. Weinberg BD, Blanco E, Gao J. Polymer implants for intratumoral drug delivery and cancer therapy. J Pharm Sci 2008; 97: 1681-1702
30. Vasilev K, Cook J, Griesser HJ. Antibacterial surfaces for biomedical devices. Expert Rev Med Devic 2009; 6: 553-567